Galectin-3 synergizes with CD47 to Suppress Phagocytosis and T cell immunity in Peritoneal Metastases of Gastric Adenocarcinoma

Authors

Yibo Fan, The University of Texas MD Anderson Cancer Center
Shilpa S. Dhar, The University of Texas MD Anderson Cancer Center
Jiankang Jin, The University of Texas MD Anderson Cancer Center
Xiaodan Yao, The University of Texas MD Anderson Cancer Center
Ruiping Wang, The University of Texas MD Anderson Cancer Center
Ailing W. Scott, The University of Texas MD Anderson Cancer Center
Melissa Pool Pizzi, The University of Texas MD Anderson Cancer Center
Lang Ma, The University of Texas MD Anderson Cancer Center
Shan Shao, The University of Texas MD Anderson Cancer Center
Matheus Sewastjanow Da Silva, The University of Texas MD Anderson Cancer Center
Jingjing Wu, The University of Texas MD Anderson Cancer Center
Namita Shanbhag, The University of Texas MD Anderson Cancer Center
Linghua Wang, The University of Texas MD Anderson Cancer Center
Michael Curran, The University of Texas MD Anderson Cancer Center
Shumei Song, The University of Texas MD Anderson Cancer Center
Jaffer A. Ajani, The University of Texas MD Anderson Cancer Center

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00054

Publication Date

2022

Department

GI Medical Oncology

Research Category

Unleashing the Immune System to Develop Therapeutic Strategies

Recommended Citation

Fan, Yibo; Dhar, Shilpa S.; Jin, Jiankang; Yao, Xiaodan; Wang, Ruiping; Scott, Ailing W.; Pizzi, Melissa Pool; Ma, Lang; Shao, Shan; Sewastjanow Da Silva, Matheus; Wu, Jingjing; Shanbhag, Namita; Wang, Linghua; Curran, Michael; Song, Shumei; and Ajani, Jaffer A., "Galectin-3 synergizes with CD47 to Suppress Phagocytosis and T cell immunity in Peritoneal Metastases of Gastric Adenocarcinoma" (2022). Leading Edge of Cancer Research Symposium. 62.
doi:https://doi.org/10.52519/00054